From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.
In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.
FDA approves Unloxcyt, a new drug by Checkpoint Therapeutics, for the treatment of advanced and metastatic cutaneous squamous cell carcinoma, showing promising results in clinical studies.
Study published in the Journal of the American Academy of Dermatology explores key symptoms and detection strategies for melanoma recurrence, providing potential improvements for surveillance protocols.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A recent study published in JAMA Dermatology revealed the significant efficacy of nemolizumab in reducing pruritus and skin lesions in patients with moderate to severe prurigo nodularis.
Recent study in JAMA Dermatology shows patients with cutaneous lupus erythematosus have a 72% higher risk of developing atherosclerotic cardiovascular disease, emphasizing the need for targeted screening and management.
A recent study in JAMA Dermatology reveals that over 65% of Merkel cell carcinoma cases in the US may be attributed to ultraviolet radiation exposure, while 63.8% may be linked to the Merkel cell polyomavirus.
Candace S. Johnson, PhD, President and Chief Executive Officer of Roswell Park Comprehensive Cancer Center, recently announced the appointment of Michael Wong, MD, PhD, FRPC, as the cancer center’s fi...